Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential

Myasthenia gravis (MG) is an autoimmune disease leading to varying degrees of skeletal muscle weakness. It is caused by specific antibodies directed against definite components in the postsynaptic membrane at the neuromuscular junction (NMJ), such as the acetylcholine receptor (AChR) and the muscle-...

Descripción completa

Detalles Bibliográficos
Autores principales: Lepedda, Antonio Junior, Deiana, Giovanni Andrea, Lobina, Omar, Nieddu, Gabriele, Baldinu, Paola, De Muro, Pierina, Andreetta, Francesca, Sechi, Elia, Arru, Giannina, Corda, Davide Giacomo, Sechi, Gian Pietro, Formato, Marilena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740073/
https://www.ncbi.nlm.nih.gov/pubmed/31588250
http://dx.doi.org/10.1177/1849454419875912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740073/
https://www.ncbi.nlm.nih.gov/pubmed/31588250
http://dx.doi.org/10.1177/1849454419875912

Ejemplares similares